
|Articles|November 6, 2015 (Updated: November 15, 2020)
Patient Engagement & Rare Diseases Podcast
Author(s)DIA
Advertisement
Durhane Wong-Rieger, President & CEO of the Canadian Organization for Rare Disorders speaks with Global Forum Deputy Editor Alberto Grignolo about patient involvement and engagement, and the future of drug development for rare diseases on DIA’s podcast channel,
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Patent Term Extension: Challenges with Defining and Claiming Approved Biologics
2
Novo Nordisk Invests $506 Million in Ireland Manufacturing Facility Expansion
3
FDA Approves New Indication of Palynziq for Patients 12 Years and Older with Phenylketonuria
4
Real-World Data Brings New Insights to Natural History of Disease Studies
5




